David Drutz
CIK 1428764 · Executive Chairman and CMO · last filed 2024-08-20
David Drutz is an Executive Chairman and CMO who has filed 38 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for ALT, was dated Aug 20, 2024. Across all open-market trades the lifetime net is +$50.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $218.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$218.9K
2
38
$50.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | Director | 83,859 | $2.61 | $218.9K | -$35.8K | 21 | 2024-08-20 |
| Midatech Pharma US Inc. (DARA) Delisted | Executive Chairman and CMO | 0 | — | — | $85.7K | 17 | 2015-12-07 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-20 | ALT | Mixed | +25,739 | -$4.2K | EDGAR |
| 2023-09-29 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-08-15 | ALT | Buy (P) | +300 | $862 | EDGAR |
| 2023-03-27 | ALT | Buy (P) | +9,000 | $38.4K | EDGAR |
| 2022-11-21 | ALT | Exer (M) | +139 | $334 | EDGAR |
| 2022-09-30 | ALT | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | ALT | Buy (P) | +1,000 | $8.0K | EDGAR |
| 2022-05-25 | ALT | Buy (P) | +1,200 | $5.4K | EDGAR |
| 2022-02-16 | ALT | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | ALT | Exer (M) | +70 | $168 | EDGAR |